Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement. (2023). Cardiology and Cardiovascular Medicine, 7(4), 265-272. https://fortunejournals.org/ojs/index.php/ccm/article/view/16422